Trials / Sponsors / Li Xiao Wei
Li Xiao Wei
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus Hepatocellular Carcinoma With PVTT | Phase 2 | 2024-03-01 |